Menitorix powder and solvent for solution for injection. Haemophilus type b and Meningococcal group C conjugate vaccine
- Licence status
- Active substances
- Conjugate of haemophilus influenzae type b capsular polysaccharide (polyribosylribitol phosphate) and tetanus, Conjugate of neisseria meningitides c capsular polysaccharide and tetanus toxoid (mean tt/ps ratio :1)
- Dosage Form
- Powder and solvent for solution for injection
- Licence number
- PA1077/116/001
- Licence holder
- GlaxoSmithKline (Ireland) Limited
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- J07AG53 hemophilus influenzae B, combinations with meningococcus C, conjugated
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 15/02/2008